Low LDL-C Levels Linked to Reduced Risk for Dementia
Statin use linked to reduction in risks for all-cause dementia and Alzheimer disease-related dementia
Racial Disparities Seen in Unintentional Overdose Mortality
Black men and Black women have pronounced and increasing burden of mortality compared with Whites
Medical Cannabis Improves Health-Related Quality of Life With Chronic Conditions
Additionally, specific symptom improvement seen
AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS
Tolebrutinib treatment associated with 31 percent risk reduction in six-month confirmed disability progression versus placebo
Only Half of U.S. Adults Can Afford Health Care and Prescriptions
Rate of unaffordability increased significantly among Black, Hispanic, and lower-income individuals
AAN: Tavapadon as Adjunct to Levodopa Ups Daily ON Time in Parkinson Disease
Significant reduction also seen in change from baseline in daily OFF times versus placebo
Semaglutide Ups Risk for Nonarteritic Anterior Ischemic Optic Neuropathy in Diabetes
Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date
Federal Funding Cuts Would ‘Decimate’ Medical Research, Expert Warns
Biden Plan to Expand Obesity Drug Coverage Is Rejected
Rates of Dissatisfaction High for Hidradenitis Suppurativa Care
74 percent of respondents unaware of FDA-approved treatments; 56 percent said these options had not been discussed by clinician
